Detailed Explanation of Overseas IVF Hospital Service Process: Complete Timeline from First Consultation to Transfer

Opening: Hospital Process Perspective

A 42-year-old patient with diminished ovarian reserve (AMH 0.6, antral follicle count 3) asked during the first consultation: What is the essential difference between the service process of overseas IVF hospitals and domestic ones? What preparations do I need to make in advance? This question reflects a core need — not simply to know the names of the steps, but to understand what each step specifically entails, why it is done, and how the process adjusts under different conditions.

The service process of overseas IVF hospitals is essentially a standardized medical pathway established around in vitro fertilization-embryo transfer (IVF-ET). However, compared with domestic routine processes, there are significant differences in cycle management, patient participation methods, legal and documentation requirements, and multidisciplinary collaboration models. Below, from the perspective of a reproductive doctor, the core process is broken down clearly.

Overseas IVF Hospital Service Process: Seven Core Stages

Regardless of which country or hospital is chosen, a complete overseas IVF cycle includes the following seven stages. Each stage has clear medical goals and time points.

The above seven stages constitute the standard service process of overseas IVF hospitals. However, for each individual, the process will undergo important adjustments in details. The following analysis is carried out from several key dimensions.

Process Differences by Age Group

Age is the primary variable affecting the arrangement of the overseas IVF process, mainly because the quality of oocytes and ovarian reserve decline at different rates with age.

Individuals under 35

• Ovarian reserve is usually normal (AMH > 1.5, antral follicle count > 8), ovulation induction mainly uses conventional antagonist protocols, with expected good egg yield.
• Blastocyst formation rate is higher (50-65%), high probability of having enough transferable embryos after PGT-A testing, making it easier to arrange fresh transfer or direct frozen embryo transfer after PGT.
• Time planning is relatively flexible, generally controlled within 8-12 weeks from first consultation to transfer.

Individuals aged 36-40

• Ovarian reserve begins to decline (AMH 0.8-1.5), requiring more attention to individualized ovulation induction protocols; some patients may need PPOS or mild stimulation protocols.
• Blastocyst formation rate drops to 40-55%; PGT-A is not mandatory but recommended due to increased aneuploidy rate. The process may require arranging 2-3 consecutive ovulation induction cycles to accumulate embryos.
• It is recommended to reserve 3-6 months on the timeline, including possible multi-cycle strategies.

Individuals over 41

• Ovarian reserve is significantly decreased (AMH < 0.8, antral follicle count < 5), ovulation induction mainly uses mild stimulation or natural cycles, with usually low egg yield (1-4).
• Blastocyst formation rate is below 35%, aneuploidy rate exceeds 70%, PGT-A is strongly recommended. In most cases, embryo accumulation is needed, and the process cycle is usually extended to 6-12 months.
• Chromosome karyotype analysis, endometrial receptivity analysis (ERA), and hysteroscopic evaluation should be completed in advance to rule out the impact of uterine factors on transfer success.

Process Differences by Country

The service process of overseas IVF hospitals varies significantly between countries, mainly reflected in legal frameworks, medical standards, and patient participation models.

Country choice directly affects the complexity of the process, required time, and total cost. The core advice is: first clarify your own medical needs (age, ovarian reserve, need for PGT, need for egg donation or third-party assistance), then match the country's legal and medical resources, rather than deciding on a country first and then adjusting the plan.

Process Differences by Hospital

Even within the same country, there are significant differences in process details between different hospitals. These differences are often overlooked but actually affect the patient's consultation experience and cycle efficiency.

• First Consultation Method: Some hospitals accept fully online first consultations (video consultation + electronic medical records), requiring patients to come to the hospital only before egg retrieval or transfer; others require the first visit to be in person for record establishment. For patients needing multiple trips, the former is significantly more time-saving.
• Ovulation Induction Monitoring Model: Some hospitals require patients to come for monitoring daily (e.g., some hospitals in Japan), while others allow patients to be monitored at a local hospital and upload data remotely (e.g., some hospitals in the US). The monitoring model determines the length of stay abroad.
• Embryo Culture Strategy: Different hospitals have differences in blastocyst culture rates, PGT testing thresholds, and whether assisted hatching is routine. These details affect blastocyst formation rates and transfer strategies.
• Transfer Policy: Some hospitals prefer fresh transfer, believing it avoids freeze-thaw damage; others insist on frozen embryo transfer, believing it allows better control of the endometrial environment and reduces OHSS risk. The process arrangements for the two paths are completely different.
• Communication and Coordination: Whether Chinese coordinators are available, whether 24-hour online consultation is provided, and whether there is a clear cycle management app or system — these soft parts of the service process have a significant impact over long cycles.

Easily Overlooked Details

In the overseas IVF service process, there are some steps that are not on the core medical path, but if missed or insufficiently prepared, can directly lead to cycle delays or even cancellation.

Documents and Legal Papers

• Passport validity must cover the entire cycle plus at least 6 months (some countries require validity exceeding 1 year).
• Marriage certificate notarization + translation (some countries require dual authentication); if egg donation or third-party assistance is involved, additional legal power of attorney is needed.
• Hospital record establishment usually requires original ID documents of both partners; some hospitals require the original marriage certificate.

Validity of Examination Reports

• Infectious disease screening (HIV, hepatitis B, syphilis, etc.) is usually valid for 6 months; semen analysis valid for 3-6 months; AMH and hormone tests valid for 3-6 months.
• Chromosome karyotype analysis and genetic carrier screening are usually valid for life, but some hospitals require reports from within the last 3 years.
• If planning PGT-M (monogenic disease testing), family verification and probe design need to be completed 3-6 months in advance; this time must be included in the process planning.

Utilization of the Menstrual Cycle

• Most examinations need to be done at specific times of the menstrual cycle (e.g., hormone panel on days 2-4, antral follicle count on days 2-5, hysteroscopy 3-7 days after menstruation ends).
• If a monthly window is missed, the overall process may be delayed by 1-2 months. It is recommended to start tracking the menstrual cycle 3 months before the planned start and schedule examinations in advance.

Obtaining Luteal Phase Support Medications

• The available forms of luteal phase support medications differ by country (oral, vaginal gel, injection, suppository). If returning home after an overseas transfer, confirm whether equivalent medications can be prescribed locally, or bring the entire cycle's supply from the hospital in advance.
• Some countries (e.g., the US) have specific restrictions on carrying medications out of the country, requiring a prescription and customs documentation in advance.

Time Planning

Time planning for overseas IVF is not simply go to the hospital and get it done, but a process requiring precise coordination. Below is a typical timeline reference.

This timeline represents the most ideal scenario. In practice, many patients may need to adjust the plan due to poor ovarian response, need for embryo accumulation, unsatisfactory PGT results, or endometrial issues, and cycle extension to 6 months or even over a year is normal.

Factors Influencing Cost

The cost of overseas IVF is highly correlated with the service process. Different process designs correspond to different cost structures. Below are the most core factors influencing cost.

• Ovulation Induction Protocol and Medication Type: Imported ovulation induction drugs (Gonal-f, Pergoveris, etc.) are more expensive than domestic ones; mild stimulation protocols have lower drug costs but may require multiple cycles to accumulate embryos, so total cost may not necessarily be lower.
• PGT Testing Type and Scope: PGT-A (chromosome number screening) costs approximately $3,000-$6,000; PGT-M (monogenic disease testing) requires additional family probe design costs ($5,000-$15,000); the more embryos tested, the higher the average cost.
• Transfer Strategy: Fresh transfer costs less than frozen embryo transfer (saving freezing costs and subsequent endometrial preparation costs), but frozen embryo transfer is routine in some hospitals.
• Hospital Location and Living Costs: Living expenses, accommodation costs, and translation costs vary greatly between countries. Total cycle cost (medical + living) in the US is typically $30,000-$60,000; in Southeast Asian countries, $15,000-$30,000; in Central Asian/Eastern European countries, $10,000-$20,000.
• Additional Medical Services: ERA (endometrial receptivity analysis), hysteroscopy, semen freezing, embryo freezing and storage fees, etc., typically range from $500 to $3,000 per item.

—— Reproductive Doctor · Knowledge Base Content —— This article is compiled based on common clinical questions and aims to provide an objective medical process reference. It does not constitute specific medical advice, nor does it represent the official position of any hospital. Please discuss individualized plans in person with your attending physician.